• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病中的神经束切开术

Compactotomy in Huntington's chorea.

作者信息

Bonelli R M, Kenner L, Gruber A, Reisecker F, Költringer P

机构信息

Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria.

出版信息

Med Hypotheses. 2001 Oct;57(4):491-6. doi: 10.1054/mehy.2001.1372.

DOI:10.1054/mehy.2001.1372
PMID:11601877
Abstract

Advances in neuroradiological and neurosurgical techniques have lead to a growing interest in functional neurosurgical interventions for medically intractable movement disorders. The majority of these procedures are performed in patients with hypokinetic movement disorders, especially Parkinson's disease. However, relatively few interventions were done in hyperkinetic disorders such as Huntington's disease (HD), mainly owing to the lack of an adequate target nucleus. We have recently described the case of a reversible chorea in a genetically confirmed HD patient. We subsequently identified a marked bilateral degeneration of the substantia nigra as the probable reason for choreatic cessation. We therefore suggest that primary striatal atrophy causing hyperkinesia and secondary substantia nigra atrophy favouring hypokinesia were balanced in this patient, thus resulting in a close-to-physiologic GABAergic basal ganglia output. We postulate that deep brain stimulation of the substantia nigra pars compacta may ameliorate hyperkinesia in choreatic movement disorders, thus representing the first effective therapy in Huntington's chorea. Several lines of evidence in recent neurophysiological research support our hypothesis and are discussed below.

摘要

神经放射学和神经外科技术的进步使得人们对针对药物难治性运动障碍的功能性神经外科干预越来越感兴趣。这些手术大多数是针对运动减少性运动障碍患者进行的,尤其是帕金森病患者。然而,针对诸如亨廷顿舞蹈病(HD)等运动增多性疾病的干预相对较少,主要是由于缺乏合适的靶点核团。我们最近报道了一例基因确诊的HD患者出现可逆性舞蹈症的病例。我们随后发现黑质明显的双侧变性是舞蹈症停止的可能原因。因此我们认为,该患者中导致运动增多的原发性纹状体萎缩和有利于运动减少的继发性黑质萎缩达到了平衡,从而产生了接近生理状态的GABA能基底神经节输出。我们推测,对黑质致密部进行深部脑刺激可能会改善舞蹈症运动障碍中的运动增多,从而成为亨廷顿舞蹈病的首个有效治疗方法。近期神经生理学研究的几条证据支持了我们的假设,将在下文进行讨论。

相似文献

1
Compactotomy in Huntington's chorea.亨廷顿舞蹈病中的神经束切开术
Med Hypotheses. 2001 Oct;57(4):491-6. doi: 10.1054/mehy.2001.1372.
2
Chapter 33: the history of movement disorders.第33章:运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
3
Huntington's disease: survival of large striatal neurons in the rigid variant.
Ann Neurol. 1984 Feb;15(2):154-6. doi: 10.1002/ana.410150207.
4
Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.帕金森病和亨廷顿病移植的神经心理学及行为学方面
Brain Cogn. 2000 Mar;42(2):294-306. doi: 10.1006/brcg.1999.1105.
5
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.在亨廷顿舞蹈病大鼠模型中,通过抑制内源性大麻素摄取减轻运动多动和神经化学缺陷。
Synapse. 2002 Apr;44(1):23-35. doi: 10.1002/syn.10054.
6
Substance P appears reduced in Huntington's disease: immunocytochemical findings in substantia nigra and substantia gelatinosa.
J Submicrosc Cytol. 1983 Apr;15(2):569-82.
7
A quantitative investigation of the substantia nigra in Huntington's disease.
Ann Neurol. 1989 Jul;26(1):13-9. doi: 10.1002/ana.410260103.
8
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。
Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.
9
Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington's disease: technical case report.双侧内侧苍白球刺激治疗亨廷顿舞蹈症:技术病例报告
Neurosurgery. 2006 Feb;58(2):E383; discussion E383. doi: 10.1227/01.NEU.0000195068.19801.18.
10
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.左旋多巴可增强帕金森病患者黑质网状部的突触可塑性。
Brain. 2009 Feb;132(Pt 2):309-18. doi: 10.1093/brain/awn322. Epub 2008 Dec 2.